Pricing

Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026)

There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required. Compounded programmes run $147 to

Answer by definition, because “cheapest” is five different questions

Most rankings publish one number. That number is almost always the advertised entry price on the longest prepaid plan, which is the least representative figure available. Here is each definition answered separately.

The five things that make a cheap price expensive

These are the mechanisms that separate an advertised figure from what you actually pay. For each, we name which providers in our dataset do it.

1. Membership stacking

A low medication price with a separate required fee on top. In our dataset memberships run from $19.99 to $149 a month: PlushCare $19.99, WeightWatchers Clinic $74, Mochi Health $79, Eden $99, and Hims, Hers and Ro all at $149.

At the top of that range the membership can equal the medication. Hims and Hers charge $149 for the oral Wegovy tablet plus $149 membership — a product NovoCare sells direct for $149 with no membership at all.

No separate membership: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Found, Henry Meds and Sprout Health on a provider-reported basis.

2. Dose-escalation pricing — the dose tax

The label directs 2.5 mg for four weeks, then 5 mg, then increases in 2.5 mg increments no sooner than every four weeks, to a maximum of 15 mg. It names 5, 10 and 15 mg as the recommended maintenance dosages and states that 2.5 mg is not approved as a maintenance dosage.

So an advertised entry price describes four weeks of a treatment you will take for years.

Escalates: LillyDirect ($299 → $399 → $449 by dose), Shed, and MEDVi (reported to reach $499 at maintenance doses).

Holds price at every covered dose: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Mochi Health, Eden, Enhance.MD and Found on a provider-reported basis.

3. Introductory versus ongoing rate

Eleven programmes in our dataset advertise a discounted first month. Hims, Hers and Mochi Health at $39; WeightWatchers Clinic at $25; PlushCare free on some plans; Enhance.MD at $112 rolling to $212.

Every one is excluded from every ranking on this site. A first-month rate applies to one month of an indefinite treatment.

4. Prepayment and what it puts at risk

The lowest advertised rates almost always require paying a full term upfront. Found is $169 prepaid against $289 month-to-month — a 71% premium for flexibility, the widest gap in our dataset. NexLife (opens nexlife.us in a new tab) is $186 against $215, a 16% premium.

Two risks belong with a twelve-month commitment. In SURMOUNT-1, 4.3% to 7.1% of participants discontinued because of adverse events depending on dose — you are committing before you know whether you tolerate it. And the FDA has proposed excluding tirzepatide from the 503B bulks list, with the comment period closed 30 July 2026 and no determination published.

Get the refund position for a regulatory interruption in writing before prepaying. Almost no provider publishes it.

5. What the price does not include

Laboratory work is the field we most often cannot establish from a published page. Shipping, consultation and supplies are usually included in compounded programmes and usually stated; labs frequently are not.

Ask specifically: are labs required, are they included, or are they billed to me or my insurance?

What our figures mean, and what they do not

Every price on this site carries an evidence status. Six of 54 records are verified — meaning a named researcher opened the provider's own published pricing page, read the figure, and archived it with a date. All six are NexLife (opens nexlife.us in a new tab), captured 11 July 2026.

The remaining 48 are provider-reported: stated by a provider or a third-party dataset, not checked by us. They may be perfectly accurate. Nobody here has confirmed them, and we will not describe an unchecked number as verified because another site published it.

That is a smaller verified count than some competitors publish, and we would rather show the real number than inflate it. The capture programme is running; the count will rise.

Where NexLife actually ranks

NexLife (opens nexlife.us in a new tab) is not the cheapest advertised price. Programmes advertise entry rates from around $99. NexLife (opens nexlife.us in a new tab) is $215 month-to-month, falling to $195 on three months, $190 on six and $186 on twelve.

What distinguishes it is that the price does not change as the dose rises, there is no membership fee, and it is the only provider whose pricing we captured ourselves. If you titrate to a maintenance dose — which the label expects — a flat rate is frequently cheaper across a year than a lower advertised rate that escalates.

Where a competitor is cheaper we publish it: Found is reported at $169 for standard compounded tirzepatide, below NexLife (opens nexlife.us in a new tab)'s captured $186, on a twelve-month prepaid plan against a $289 month-to-month rate.

Compounded against approved, honestly

Compounded tirzepatide is not FDA-approved. It has not been reviewed for safety, effectiveness or manufacturing quality, it is not a generic, and no trial has studied any compounded preparation. The SURMOUNT figures quoted across this market come from trials of the approved product at studied doses.

That is not an argument against it. It is the trade being made, and it should be made knowingly. Brand Zepbound at $299 direct is now close enough to the upper half of the compounded market that the trade is worth re-running — sixteen compounded offerings in our dataset cost more than $299.

Before you pay anyone

1. Check insurance first. It beats every route on this page.
2. Ask what you pay at 10 mg, not at the starting dose.
3. Ask which pharmacy fills the prescription and whether it is 503A or 503B. No provider in our dataset has told us.
4. Ask whether labs are required and included.
5. Get the refund position in writing before prepaying anything.

Questions readers actually ask

Capture standing: 15 of 70 price records in this dataset were read at the source by us: 9 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.